1-45331833-C-G

Variant summary

Our verdict is Likely benign.
-4 Likely Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -4 classification points (ACGS-UK Somatic Oncogenicity v2025): 1P and 5B. O4_SupportingB1_StrongB3_Supporting

The NM_001048174.2(MUTYH):c.930G>C (p.Gln310His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The gene MUTYH is a cancer driver gene (CancerMine: 2 driver citations). The variant allele was found at a cumulative frequency of 0.261 (AC=418,548) in the gnomAD database across 1,603,502 control chromosomes, including 56,797 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.472. In-silico predictor (REVEL) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (★★). Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.Q310E: Uncertain_significance (ClinVar VariationId 4112922, 1 star); p.Q310H: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 492713); p.Q310K: Uncertain_significance (ClinVar VariationId 4112921, 1 star); p.Q310L: Benign (ClinVar VariationId 485901, 1 star); p.Q310P: Uncertain_significance (ClinVar VariationId 4112923, 1 star); p.Q310= (synonymous): Likely_benign (ClinVar VariationId 1740087, 1 star); p.Q310R: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 127836); p.Q310R: Benign/Likely_benign (ClinVar VariationId 142590, 2 stars) The variant has been observed in cBioPortal in 11 samples across 6 studies and 10 cancer types; somatic enrichment level: SUPPORTING (Observed repeatedly in cBioPortal somatic datasets.). This exact variant is curated in the UniProt human variants database as Uncertain Significance; it is also listed as a COSMIC curated somatic variant.

Frequency

Genomes: 𝑓 0.27 ( 5852 hom., cov: 33)
Exomes 𝑓: 0.26 ( 50945 hom. )

Consequence

MUTYH
NM_001048174.2 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:22O:1

Conservation

PhyloP100: -0.265

Publications

182 publications found
Variant links:
Genes affected
MUTYH (HGNC:7527): (mutY DNA glycosylase) This gene encodes a DNA glycosylase involved in oxidative DNA damage repair. The enzyme excises adenine bases from the DNA backbone at sites where adenine is inappropriately paired with guanine, cytosine, or 8-oxo-7,8-dihydroguanine, a major oxidatively damaged DNA lesion. The protein is localized to the nucleus and mitochondria. This gene product is thought to play a role in signaling apoptosis by the introduction of single-strand breaks following oxidative damage. Mutations in this gene result in heritable predisposition to colorectal cancer, termed MUTYH-associated polyposis (MAP). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2017]
MUTYH Gene-Disease associations (from GenCC):
  • familial adenomatous polyposis 2
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, G2P, ClinGen
  • colorectal cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • familial ovarian cancer
    Inheritance: AD, AR Classification: NO_KNOWN Submitted by: ClinGen
  • hereditary breast carcinoma
    Inheritance: AD, AR Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001048174.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 points.

O4
Enriched in cBioPortal (pre-computed score ≥ 1.0) — Supporting (O4); cBioPortal: samples=11 | studies=6 | cancer types=10 | level=SUPPORTING | points=1.0 | reason: Observed repeatedly in cBioPortal somatic datasets.
B1
GnomAD effective popmax AF >1% — B1 stand-alone benign; GnomAD effective popmax AF = 0.472 — exceeds 1% threshold (B1 applied)
B3
Computational evidence does not support a deleterious effect; Missense variant — primary computational scorer does not support an oncogenic/deleterious effect; supports B3

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_001048174.2. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MUTYH
NM_001128425.2
MANE Plus Clinical
c.1014G>Cp.Gln338His
missense
Exon 12 of 16NP_001121897.1E5KP25
MUTYH
NM_001048174.2
MANE Select
c.930G>Cp.Gln310His
missense
Exon 12 of 16NP_001041639.1Q9UIF7-6
MUTYH
NM_012222.3
c.1005G>Cp.Gln335His
missense
Exon 12 of 16NP_036354.1Q9UIF7-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MUTYH
ENST00000710952.2
MANE Plus Clinical
c.1014G>Cp.Gln338His
missense
Exon 12 of 16ENSP00000518552.2E5KP25
MUTYH
ENST00000456914.7
TSL:1 MANE Select
c.930G>Cp.Gln310His
missense
Exon 12 of 16ENSP00000407590.2Q9UIF7-6
MUTYH
ENST00000372098.7
TSL:1
c.1005G>Cp.Gln335His
missense
Exon 12 of 16ENSP00000361170.3Q9UIF7-1

Frequencies

GnomAD3 genomes
AF:
0.269
AC:
40958
AN:
152016
Hom.:
5824
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.264
Gnomad AMI
AF:
0.274
Gnomad AMR
AF:
0.400
Gnomad ASJ
AF:
0.262
Gnomad EAS
AF:
0.412
Gnomad SAS
AF:
0.238
Gnomad FIN
AF:
0.215
Gnomad MID
AF:
0.269
Gnomad NFE
AF:
0.243
Gnomad OTH
AF:
0.297
GnomAD2 exomes
AF:
0.290
AC:
67377
AN:
232316
AF XY:
0.277
show subpopulations
Gnomad AFR exome
AF:
0.263
Gnomad AMR exome
AF:
0.488
Gnomad ASJ exome
AF:
0.263
Gnomad EAS exome
AF:
0.397
Gnomad FIN exome
AF:
0.220
Gnomad NFE exome
AF:
0.244
Gnomad OTH exome
AF:
0.288
GnomAD4 exome
AF:
0.260
AC:
377531
AN:
1451368
Hom.:
50945
Cov.:
42
AF XY:
0.257
AC XY:
185520
AN XY:
721162
show subpopulations
African (AFR)
AF:
0.266
AC:
8835
AN:
33194
American (AMR)
AF:
0.477
AC:
20523
AN:
43026
Ashkenazi Jewish (ASJ)
AF:
0.261
AC:
6710
AN:
25756
East Asian (EAS)
AF:
0.420
AC:
16507
AN:
39306
South Asian (SAS)
AF:
0.233
AC:
19899
AN:
85350
European-Finnish (FIN)
AF:
0.228
AC:
11904
AN:
52316
Middle Eastern (MID)
AF:
0.292
AC:
1643
AN:
5630
European-Non Finnish (NFE)
AF:
0.249
AC:
275322
AN:
1106868
Other (OTH)
AF:
0.270
AC:
16188
AN:
59922
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
18127
36253
54380
72506
90633
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9744
19488
29232
38976
48720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.270
AC:
41017
AN:
152134
Hom.:
5852
Cov.:
33
AF XY:
0.270
AC XY:
20054
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.263
AC:
10933
AN:
41514
American (AMR)
AF:
0.401
AC:
6123
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.262
AC:
909
AN:
3470
East Asian (EAS)
AF:
0.412
AC:
2127
AN:
5162
South Asian (SAS)
AF:
0.238
AC:
1147
AN:
4824
European-Finnish (FIN)
AF:
0.215
AC:
2275
AN:
10594
Middle Eastern (MID)
AF:
0.272
AC:
80
AN:
294
European-Non Finnish (NFE)
AF:
0.243
AC:
16532
AN:
67978
Other (OTH)
AF:
0.305
AC:
642
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1552
3103
4655
6206
7758
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
422
844
1266
1688
2110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.250
Hom.:
1622
Bravo
AF:
0.287
Asia WGS
AF:
0.359
AC:
1247
AN:
3478

Local populations

ToMMo 61KJPN (+60KJPN MNV)
AF:
0.457
AC:
56071
AN:
122724
Turkish Variome
AF:
0.261
AC:
1701
AN:
6524
Hom.:
239
WBBC (Westlake BioBank for Chinese) pilot
AF:
0.376
AC:
3373
AN:
8960
Hom.:
613
ABraOM SABE-WGS-1171
AF:
0.308
AC:
721
AN:
2342
Hom.:
120

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
8
not specified (9)
-
-
4
Familial adenomatous polyposis 2 (4)
-
-
4
Hereditary cancer-predisposing syndrome (4)
-
-
4
not provided (4)
-
-
1
Carcinoma of colon (1)
-
-
1
Familial multiple polyposis syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.68
T
BayesDel_noAF
Benign
-0.61
CADD
Benign
14
DANN
Benign
0.80
DEOGEN2
Benign
0.086
T
Eigen
Benign
-0.58
Eigen_PC
Benign
-0.61
FATHMM_MKL
Benign
0.15
N
LIST_S2
Benign
0.44
T
MetaRNN
Benign
0.0010
T
MetaSVM
Benign
-0.93
T
MutationAssessor
Uncertain
2.7
M
PhyloP100
-0.27
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-1.0
N
REVEL
Benign
0.043
Sift
Benign
0.17
T
Sift4G
Benign
0.12
T
PromoterAI
-0.00020
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.12
gMVP
0.51
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs3219489;
hg19: chr1-45797505;
COSMIC: COSV58343790;
COSMIC: COSV58343790;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.